Maine Medical Center, Pancreaticobiliary Center, Portland, Maine 04102, USA.
Am J Gastroenterol. 2011 Feb;106(2):294-9. doi: 10.1038/ajg.2010.447. Epub 2010 Nov 23.
OBJECTIVES: Techniques of tissue sampling at endoscopic retrograde cholangiopancreatography (ERCP) have been underutilized due to technical demands, low yield, and lack of immediate intraprocedural diagnosis. The objective of this study was to describe a new inexpensive, highly efficient ERCP tissue processing, and interpretation technique to address these issues. METHODS: A retrospective, institutional review board approved, single-center study was done at a tertiary-care medical center. Between June 2004 and February 2009, 133 patients (age 38-95 years; men 53%) with suspicious biliary strictures underwent ERCP with tissue sampling using a new technique. Small forceps biopsy specimens were forcefully smashed between two dry glass slides, immediately fixed, stained with rapid Papanicolaou, and interpreted by an on-site pathologist during the procedure (Smash protocol). RESULTS: Of the 117 proven to have cancer, true-positive Smash preps included pancreatic cancer 49/66 (74%), cholangiocarcinoma 23/29 (79%), metastatic cancer 8/15 (53%), and other 4/7 (57%). The median number of Smash biopsies to diagnosis was 3 (range 1-17). Suspicious or atypical results were considered to be negative in this study. There were no false positives and no complications. Smash had an overall sensitivity of 89/117 (76%) for all cases. The true-positive yield of immediate Smash prep cytology, combined with ERCP fine needle aspirate (FNA) and forceps biopsy histology was 77/95 (81%) for primary pancreaticobiliary cancers. CONCLUSIONS: Immediate cytopathologic diagnosis at ERCP was established in 72% of patients presenting with suspected malignant biliary obstruction using a new cytological preparation of forceps biopsies. This approach to ERCP tissue sampling permits immediate diagnosis and avoids the need for subsequent procedures, adds little cost and time, and is safe to perform.
目的:由于技术要求高、产量低以及缺乏即时的术中诊断,内镜逆行胰胆管造影(ERCP)中的组织采样技术尚未得到充分利用。本研究的目的是描述一种新的廉价、高效的 ERCP 组织处理和解释技术,以解决这些问题。
方法:这是一项在三级医疗中心进行的回顾性、机构审查委员会批准的单中心研究。在 2004 年 6 月至 2009 年 2 月期间,133 例(年龄 38-95 岁;男性 53%)可疑胆道狭窄的患者接受了 ERCP 检查,并使用新技术进行了组织采样。小活检钳标本在两块干燥的载玻片之间强力压碎,立即固定,用快速巴氏染色,由现场病理学家在手术过程中进行解释(粉碎协议)。
结果:在 117 例确诊为癌症的患者中,真正阳性的粉碎前标本包括胰腺癌 49/66(74%)、胆管癌 23/29(79%)、转移性癌症 8/15(53%)和其他 4/7(57%)。诊断所需的粉碎活检中位数为 3 次(范围 1-17 次)。在本研究中,可疑或非典型结果被认为是阴性的。没有假阳性和并发症。粉碎术对所有病例的总体敏感性为 89/117(76%)。即时粉碎细胞学检查与 ERCP 细针抽吸(FNA)和活检组织学相结合,对原发性胰胆管癌的真阳性检出率为 77/95(81%)。
结论:使用新的活检钳细胞学制备方法,对 72%的疑似恶性胆道梗阻患者在 ERCP 时可立即进行细胞学诊断。这种 ERCP 组织采样方法可实现即时诊断,避免了后续操作的需要,增加的成本和时间很少,且操作安全。
Am J Gastroenterol. 2010-11-23
Hepatobiliary Pancreat Dis Int. 2005-2
Am J Gastroenterol. 1993-10
Gastrointest Endosc. 2016-10
World J Gastrointest Endosc. 2022-5-16
World J Gastrointest Endosc. 2020-10-16
World J Gastroenterol. 2013-11-14
World J Gastroenterol. 2012-11-21
Dig Dis Sci. 2011-12